Duke Pharmacology & Cancer Biology Department
@Duke_PCB
Followers
626
Following
225
Media
112
Statuses
580
A collaborative department with associated PhD programs broadly focused on research related to cellular signaling and its impact on disease
Joined May 2021
RT @DukeCancer: Mustafa Khasraw, MD, deputy director of the DCI Center for Cancer Immunotherapy, is at the forefront of a promising clinica….
0
1
0
RT @DukeMedSchool: A study led by #DukeMed cancer researcher Hui-Kuan Lin, PhD, reveals cancer’s weak spot – a protein that helps cells mak….
0
2
0
Congratulations, Ashley!.
🎓 We're excited to celebrate Ashley Colemon, who is graduating with a PhD in Molecular Cancer Biology (@Duke_PCB). 🔗 Read more about Ashley: 🎉 We will be highlighting some of our SOM 2025 graduates over the next few days. Stay tuned for more stories!
0
0
1
Synovial sarcoma is a rare, aggressive soft tissue cancer with few effective treatment options. Duke researchers have found a weakness in the disease, suggesting a possible new treatment. @DukeCancer @DukePathDept.
0
0
1
The latest study from Greg Wang’s lab led by Yao Yu demonstrates that targeting an integral component of lysine methyltransferase complexes, WDR5, for degradation can suppress oncogenic transcriptional programs in synovial sarcoma. @DukeCancer .Read more:
0
0
1
Tomorrow will be the final WIP of the semester. We hope to see you at noon in 143 Jones. Thanks for a great series!
0
0
0
Mei has been living with breast cancer since 1996 and tried numerous medications. That changed when she began taking a new drug called elacestrant, discovered in the lab of Dr. Donald McDonnell. #ResearchSavesLives.
1
0
1
A breast cancer drug identified in the lab of Donald McDonnell, PhD, is helping women with late-stage breast cancer.
1
0
2
Friday: WIP at 12 noon in 143 Jones
0
0
0
RT @DukeCancer: The discovery in the lab of Duke cancer pharmacologist Donald McDonnell of a new drug treatment has changed the lives of th….
0
2
0